Description:
Pharmaceutical Manufacturing,Pharmaceutical Preparations,Our medicines for cardiovascular,Daiichi Sankyo,Inc. currently markets therapies in hypertension,thrombotic disorders,stroke risk reduction,dyslipidemia,diabetes,acute coronary syndrome,opioid-induced constipation,IV iron therapy and metastatic melanoma. In addition,our research and development is primarily focused on bringing forth novel therapies in oncology,including immuno-oncology,with additional focus on new horizon areas,such as pain management,neurodegenerative diseases,heart and kidney diseases,and other rare diseases. PP-US-NP-0246 08/17,Major Drugs,Pharmaceutical Preparations,Pharmaceuticals Read More
